AROA BIOSURGERY LIMITED — Director's Dealing 2024

Oct 3, 2024

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Aroa Biosurgery Limited ARBN 638 867 473

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Catherine Mohr
Date of last notice	14 August 2023

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct & Indirect	Direct & Indirect
Nature of indirect interest	Mohr Family Trust (Beneficiary)
(including registered holder)
Note: Provide details of the circumstances giving rise to the
relevant interest.
Date of change	30 September 2024
No. of securities held prior to change	Direct
	210,686	Options exercisable at $0.87
		expiring 13 November 2027
Class	Fully Paid Ordinary Shares
Number acquired	436,364
Number disposed	-
Value/Consideration	$163,453.67
Note: If consideration is non-cash, provide details and estimated
valuation
No. of securities held after change	Direct
	210,686	Options exercisable at $0.87
		expiring 13 November 2027
	Indirect
	Mohr Family Trust
	436,364	Fully Paid Ordinary Shares

• See chapter 19 for defined terms.

01/01/2011

Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

On-market trade

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

	Detail of contract	Detail of contract	Detail of contract	-	-	-	-
	Nature of interest			-
	Name of re(if issued s	gistered holdecurities)	er	-
	Date of ch	ne		-
		g
	N d	l f	iti t
	o. anwhich int	ass o secerest related	ures oprior to	-
	changeNote: Details a	re only required for	a contract in
	relation to which	the interest has cha	nged
	Interest ac	quired		-
	Interest di	sposed		-
	Value/Con	sideration		-
	Note: If consideand an estimate	ration is non-cash,d valuation	provide details
	Interest af	er change		-

Part 3 –[+] Closed period

Were the interests in the securities No or contracts detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance N/A provided to allow the trade to proceed during this period? If prior written clearance was N/A provided, on what date was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011